Patient-family Communication Mediates the Relation Between Family Hardiness and Caregiver Positivity: Exploring the Moderating Role of Caregiver Depression and Anxiety
Overview
Authors
Affiliations
Despite the theoretical and empirical significance of positive aspects of caregiving in caregiver well-being, relatively little is known regarding family-related predictors of caregiver positivity. This study examines whether patient-family communication (p-f communication) mediates the relation between family hardiness and caregiver positivity and whether the mediating effects of p-f communication are moderated by the levels of caregiver depression and anxiety. This study used secondary data obtained from a large-scale cross-sectional national survey conducted in South Korea. Participants were 544 spousal cancer patient-caregiver dyads recruited from the National Cancer Center and nine government-designated regional cancer centers in South Korea. To test the hypotheses, a simple mediation model and two moderated mediation tests were conducted using the PROCESS macro for SPSS. Higher family hardiness was related to higher p-f positive communication and higher caregiver positivity. The effects of family hardiness were partially mediated by p-f communication, controlling for caregiver sex, education, health status, depression and anxiety, time spent caregiving, and patient depression and anxiety, cancer stage, and time since diagnosis. The mediating effects of p-f communication were not significantly moderated by caregiver depression and anxiety. Health care professionals could consider p-f communication as a reasonable target of intervention to increase caregiver positivity, even for caregivers with heightened depression and anxiety.
Ellis K, Koechlin H, Rudaz M, Gerido L, Hecht H, Jones C Cancer Med. 2024; 13(20):e70328.
PMID: 39470180 PMC: 11519995. DOI: 10.1002/cam4.70328.
Ye Q, Yang Y, Li J, Wang T, Liu N Int J Nurs Stud Adv. 2024; 7:100246.
PMID: 39391565 PMC: 11465215. DOI: 10.1016/j.ijnsa.2024.100246.
Son H, Kim N Cancers (Basel). 2024; 16(11).
PMID: 38893270 PMC: 11172360. DOI: 10.3390/cancers16112152.
Senger A, Venetis M, Greene K, Catona D, Devine K PEC Innov. 2024; 4:100259.
PMID: 38347863 PMC: 10859277. DOI: 10.1016/j.pecinn.2024.100259.
Cui P, Shi J, Li S, Getu M, Wang R, Chen C BMC Cancer. 2023; 23(1):623.
PMID: 37403053 PMC: 10320962. DOI: 10.1186/s12885-023-11101-z.